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Abstract: Diabetes resulting from insufficient insulin secretion or insulin resistance (IR) is a highly prevalent metabolic disease. Since
microRNAs have been linked with elevated IR, the current research hypothesized that miR-124-3p has a role in IR and the establishment
of IR and type 2 diabetes (T2DM). The study aimed to explore the molecular mechanisms of miR-124-3p which influence IR leading
to T2DM establishment. HepG2 cells were cultured in vitro, and palmitic acid (PA) was used to construct the IR cell model. In the IR
model, transfection of miR-124-3p or phosphoglucomutase 1 (PGM1) linked plasmids were transfected into HepG2 cells. RT-qPCR was
used to determine the miR-124-3p and PGM1 expressions in the cells. Cell viability was assessed through CCK-8 assays, while glucose
consumption was studied using a glucose uptake test. Interaction between miR-124-3p and PGM1 was examined using a dual-luciferase
reporter assay. Autophagy, phosphatidylinositol 3 kinases (PI3K)/protein kinase B (AKT) and JNK pathways-linked factors, glucose
transporter 4 (GLUT4), and c-Jun were determined through western blotting assays. MiR-124-3p expression was elevated, but PGM1
was reduced in the IR model. Glucose uptake was reduced posttreatment with 0.8 mM PA. There was a significantly increased PI3K,
p-PI3K, AKT, p-AKT, GLUT4, LC3I/II, Beclin-1, p-JNK1/2, and c-Jun, but reduced p62 expressions were presented in the PA + miR124-3p inhibitor compared to the PA and PA + inhibitor NC groups. PGM1 binds directly to miR-124-3p through the 3’ UTR region
target. Overall, miR-124-3p downregulates glucose consumption via targeting PGM1 to repress PI3K/AKT and JNK pathways. Silencing
PGM1 inhibited the suppressor role of miR-124-3p on glucose uptake, cell proliferation, and inflammation. In conclusion, miR-124-3p
reduces glucose uptake in HepG2 cells via PGM1/PI3K/AKT modulation. MiR-124-3p targets PGM1 in IR and may provide an effective
therapeutic alternative for T2DM.
Key words: Palmitic acid, microRNA-124-3p, phosphoglucomutase 1, PI3K/AKT, JNK, insulin resistance, autophagy, cell proliferation,
inflammatory response

1. Introduction
Diabetes resulting from insufficient insulin secretion or
insulin resistance (IR) is a highly prevalent metabolic
disease worldwide (Bartel et al., 2004). According to the
latest data, over 463 million adults are diagnosed with
diabetes, which is expected to rise to 700 million by 2045
(Zheng et al., 2018). Diabetes is categorized into type 1
diabetes (T1DM), type 2 diabetes (T2DM), and gestational
diabetes (GDM). T2DM is the most common, with over
90% of all diabetes cases (Galicia-Garcia et al., 2020).
Impaired insulin signaling pathway, systemic IR, and
absence of response to insulin target cells (like liver cells,
fat cells, and skeletal muscle cells) are the major factors
leading to T2DM (Saltiel et al., 2001). IR is present during
the progression of T2DM, and the metabolism in T2DM

patients can be mitigated through IR reduction (Tahrani
et al., 2011). The pathogenesis of IR is extremely complex,
and according to a previous study, increased free fatty
acids (FFA) can result in IR in the muscle and liver tissues
(Samuel et al., 2010). However, the molecular mechanisms
linking FFA and IR remain unclear. Palmitic acid (PA)
is a classic saturated free fatty acid found in animals and
plants (Gao et al., 2010). PA has been successfully induced
in IR models in cultured HepG2 cells (Ishii et al., 2015),
(Charytoniuk et al., 2019).
According to previous reports, various microRNAs
(miRNAs) have roles in the cascade of main proteins
in the insulin pathway that impact IR, for instance,
let-7f and insulin growth factor-1 receptor (Hu et al.,
2014), let-7a, and phosphatidylinositol 3 kinase (PI3K)/
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protein kinase B (AKT) (Wang et al., 2019), miR-133a
and glucose transporter 4 (GLUT4) (Horie et al., 2009).
Activated insulin receptor substrate 2 induces the PI3K/
AKT pathway to transduce insulin activity, subsequently
activating the absorption of glucose via the type 4 insulinsensitive GLUT4 in the plasma membrane (Evans et al.,
2005). MiR-124-3p negatively regulates the differentiation
of hepatocytes into insulin-producing cells (IPCs) in vitro
(Pan et al., 2020). However, the role of miR-124-3p in
T2DM is still unknown. Phosphoglucomutase 1 (PGM1)
is crucial in modulating insulin secretion (Galcheva et
al., 2018) and implicated in congenital hyperinsulinemia
(Gϋemes et al., 2020), but the mechanism and role of
PGM1 in T2DM have not been investigated.
The study hypothesized that miR-124-3p plays a role
in the IR and establishment of T2DM via the miR-124-3p/
PGM1 axis. The study aimed to determine the expression
of miR-124-3p in the insulin-resistant HepG2 cells model,
assess whether PGM1 is a target gene of miR-124-3p, and
understand the effects of miR-124-3p in proliferation
and autophagy of HepG2 cells. Finally, the effect of miR124-3p inhibition on PGM1 and T2DM progression
was investigated. The results confirmed that miR-1243p inhibits glucose uptake in HepG2 cells, miR-124-3p
facilitates cell autophagy but represses inflammation via
depressing the PI3K/AKT and JNK pathways, miR-124-3p
targets PGM1 and miR-124-3p reduces glucose uptake via
targeting PGM1 to repress PI3K/AKT and JNK pathways.
2. Materials and methods
2.1. Cell culture
The HepG2 cells used in the study were purchased from
American Type Culture Collection (ATCC) (Manassas,
VA, USA). The cells were maintained in Dulbecco’s
Modified Eagle Medium (DMEM) (Gibco, NY, USA)
supplemented with 10% fetal bovine serum, 100 U/mL
penicillin, and 0.1 mg/mL streptomycin at 37 °C and 5%
CO2. The cells were passaged in the logarithmic growth
phase at 70%–80% confluence.
2.2. Glucose uptake test
The HepG2 cells were transferred to a 6-well plate and
treated for 24 h with 0–0.8 mM PA. The glucose uptake
was assessed through the glucose oxidase assay (BioRongsheng, Shanghai, China) following the manufacturer’s
instructions. The resulting solution’s absorbance at
a wavelength of 490 nm was proportional to glucose
concentration.
2.3. Cell viability determination
The Cell Counting Kit-8 (CCK-8) assay kit (Dojindo
Molecular Technologies, Inc.) was used to detect cell
viability. The HepG2 cells were seeded into a 96-well plate
at a density of 6000 cells per well, and treatment was as
described above. Cells were then incubated with 10%

CCK-8 solution, and the absorbance was measured at 450
nm in a microplate reader (Thermo Fisher Scientific, Inc.,
USA). Each experiment was performed independently in
triplicate.
2.4. Cell transfection
The inhibitor negative control (NC), miR-124-3p inhibitor
(100 nM)(Sangon Biotech, Shangai, China), and si-NC/
PGM1 (GenePharma Co. Ltd., Shanghai, China) were
transfected into HepG2 cells using the lipofectamine 2000
transfection kit (Thermo Fisher Scientific, Waltham, MA,
USA) as per the instructions of the manufacturer. The
successfully transfected cells were cultured in serum-free
DMEM and cultivated further.
2.5. EdU assay
The BeyoClick™ EdU-555 cell proliferation detection kit
(Shanghai Biyuntian Biotechnology Co., Ltd., Shanghai,
China) was used to study cell proliferation. The 2X EdU
working solution was preheated at 37 °C and added to the
well plate in equal volume with the original culture solution
to obtain a final EdU concentration of 10 µM and finally
incubated. The culture medium was discarded and 1 mL of
4% paraformaldehyde fixative was added and incubated.
The fixative was then removed and permeabilization
solution (1 mL) made of 0.3% Triton X-100 in phosphate
buffer saline (PBS) was added to each well and further
incubated. The solution was discarded, and Click additive
was dissolved in deionized water and stored at –20 °C. For
the preparation of the Click reaction solution, each well
required: Click reaction buffer (430 μL), CuSO4 (20 μL),
Azide (5551 μL), and Click additive solution (50 μL). The
Click reaction solution (0.5 mL) was added to each well
to ensure the reaction solution evenly covered the sample.
The sample was incubated, and later, the Click reaction
solution was aspirated. The 4’, 6-diamidino-2-phenylindole
(DAPI) (1000X) was diluted with PBS at a ratio of 1: 1000,
and 1 mL was added to each well for nuclear staining. The
1X DAPI solution was then discarded, and the sample was
examined under a fluorescence microscope.
2.6. Quantitative real-time polymerase chain reaction
(qRT-PCR)
The HepG2 cells were harvested after the appropriate
treatment and washed thrice in ice-cold phosphatebuffered saline. TRIzol reagent (Life Technologies, NY,
USA) was used to extract total RNA from HepG2 cells,
and the concentration and purity of RNA were determined
using an ultra-micro spectrophotometer NanoDrop2000
(Thermo Fisher Scientific, USA). Reverse transcription of
total RNA was performed using Revert Aid First Strand
cDNA Synthesis Kit (Thermo Fisher Scientific, USA) using
1 µg of the total RNA and Oligo (dT) primers.
The cDNA was then synthesized through reverse
transcription using TaKaRa Reverse Transcription Kit
(Takara, Tokyo, Japan). The cDNA (1 μL) template was
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prepared using 0.4 μL of RT-FP (10 μmol/L), 0.4 μL of RTRP (10μmol/L), 8.2 μL of RNA-free enzyme water, and 10
μL of 2X SYBR Green Mix in a fluorescent quantitative
PCR analyzer (CFX Connect, USA). The PCR conditions
were done at 95°C for 30 s, 40 cycles of denaturation at
95°C for 5 s, then annealing at 60 °C for 30 s, extension at
95 °C for 5 s, and a final extension at 60 °C for 60 s. β-actin
was employed as an internal control to standardize RNA
expression, while U6 was an internal reference for miRNA.
The relative fold changes of the genes were analyzed by the
2-ΔΔCt method. The amplification primer sequence of each
gene and its primer was detailed in Table.
2.7. The luciferase activity assay
miRanda (www.microrna.org), PicTar (pictar.mdcberlin.de/), and TargetScan (www.targetscan.org) were
used for the prediction of miR-124-3p target genes. The
PGM1 3’-untranslated region (3’-UTR) was amplified to
gain mutant sequences using a site-directed mutation kit
(NBS company, Beijing, China). The amplified PGM1 3’UTR wild-type (WT) and mutant (MT) sequences were
inserted into the psi-CHECK2 fluorescent reporter gene
plasmid (Promega Company, USA). A luciferase reporter
assay was used to validate the prediction. Later, WT and
MT PGM1 3’-UTR plasmid, miR-124-3p mimic (100
nM), miR-124-3p inhibitor ((100 nM), and its negative
control were separately transfected into the cells using
LipofectamineTM 3000 (Thermo Fisher Scientific,
USA) transfection reagent following the manufacturer’s
instructions. The cells were harvested 48 h later, and the
luciferase activity was assessed through Dual-Luciferase
Reporter Assay System (Promega, Shanghai, China). All
the assays were done in triplicates.
Table. Primer sequence.
Name of primer

Sequences

MiR-124-3p-F

AAGTACTCTAAGGCACGCGGT

MiR-124-3p-R

CAGTGCAGGGTCCGAGGT

PGM1-F

AGCATTCCGTATTTCCAGCAA

PGM1-R

TCAGATTCCCAAAAAACTTCCAA

IL-1β-F

GGGGCGTCCTTCATATGTGT

IL-1β-R

ATACAACGGCTCCTCCGTTC

IL-6-F

GGGCTGCGATGGAGTCAGAG

IL-6-R

AGTGACTCAGCACTTTGGCAT

TNF-α-F

TGGGTAAGGAGATGCTTCCG

TNF-α-R

ATCGCGCGTTTGAAAGTGTC

U6-F

CTCGCTTCGGCAG CACA

U6-R

AACGCTTCACGAATTTGCGT

β-actin-F

CTCCATCCTGGCCTCGCTGT

β-actin-R

GCTGTCACCTTCACCGTTCC
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2.8. Western blot analysis
After a successful transfection, the HepG2 cells were lysed
in RIPA lysis buffer and PMSF at low temperatures. The
total protein concentration was detected using a BCA
assay kit (Novizan, Nanjing, China). The protein (30 μg/
lane) was separated using 10% sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE), and
the electroblot was transferred onto a polyvinylidene
fluoride membrane (Millipore, Billerica, MA, USA).
The membrane was then blocked for 1 h with 5% skim
milk diluted in tris-buffered saline of 0.1% Tween-20.
The membrane was then incubated in with the rabbit
antihuman PGM1 (ab192876, PI3K (ab191606), p-PI3K
(ab278545), AKT (ab18785), p-AKT (ab81283), GLUT4
(ab33780), Beclin-1 (ab210498), LC3I/ II (ab192890), p62
(ab109012), JNK1/2 (ab4821), p-JNK1/2, c-Jun (ab31419)
primary antibodies, all from Abcam (Cambridge, UK)
(all 1: 1000) and horseradish peroxidase-labeled goat
antirabbit immunoglobulin G (IgG) (1: 5000, Solarbio
Technology Co., Ltd.). The chemiluminescence imaging
system (Shanghai Tianneng Technology Co., Ltd.,
Shanghai, China) was used to visualize and analyze the
bands. β-actin (4970S, 1: 1000, Cell Signaling Technology,
Boston, USA) was used as a sample loading control, and
the experiment was performed three times independently.
2.9. Statistical analysis
Statistical analysis was performed with GraphPad Prism 8
software, and all the data were presented as mean ± standard
deviation. The t-test was used for two-group comparison,
while a one-way analysis of variance was used to compare
multiple groups. Dunnett’s multiple comparisons test was
used for post hoc multiple comparisons. p < 0.05 was
considered statistically significant.
3. Results
3.1. MiR-124-3p inhibits glucose uptake in HepG2 cells
The IR model was treated with PA to determine the
effects of miR-124-3p on T2DM. According to the results,
the viability of the cells was not affected following the
treatment with 0.2 to 0.8 mM PA (Figure 1A). However,
the glucose uptake was significantly reduced following
the treatment with 0.8 mM PA (Figure 1B, p < 0.05).
Consequently, a concentration of 0.8 mM PA was chosen
to induce IR in HepG2 cells. Next, the mRNA expression
of miR-124-3p was determined in the PA-treated
and control cells through RT-PCR. The observations
confirmed a significantly elevated miR-124-3p mRNA
expression in the PA-treated compared to the control cells
(Figure 1C, p < 0.01). Furthermore, miR-124-3p mRNA
expression was significantly reduced in the PA+miR-1243p inhibitor compared to the PA+ inhibitor NC or the
PA group (Figure 1D, P < 0.01), indicating a successfully
silenced miR-124-3p. Moreover, the glucose uptake assay
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confirmed a significantly increased glucose consumption
in the PA+miR-124-3p inhibitor compared to the PA+
inhibitor NC or the PA groups (Figure 1E, P < 0.05),
indicating that miR-124-3p suppressed the glucose uptake
in HepG2 cells. These observations confirmed that miR124-3p is elevated in the HepG2 IR model, consequently
reducing the glucose uptake in HepG2 cells.
3.2. MiR-124-3p facilitates cell autophagy, but repressed
inflammation via depressing the PI3K/AKT and JNK
pathways
The possible role of miR-124-3p in the PI3K/AKT pathway
was investigated through western blotting. The results
confirmed a significantly increased PI3K/AKT pathwaylinked proteins in the PA+ miR-124-3p inhibitor compared
to the PA and PA + inhibitor NC groups (Figure 2A),
confirming that miR-124-3p repressed PI3K/AKT pathway.
The role of miR-124-3p on autophagy was investigated
through western blotting. The results showed that miR124-3p enhanced autophagy (Figure 2B). Contrastingly,
p-JNK and c-Jun expressions were significantly elevated
(Figure 2C), indicating that miR-124-3p repressed PI3K/
AKT pathway. The proliferative capacity of HepG2 cells
was investigated following the transfection with PA+miR124-3p inhibitor, PA+ inhibitor NC, PA, or the control
plasmids. The observations confirmed significantly

increased proliferation of the PA+miR-124-3p inhibitor
group compared to the NC or the controls (Fig 2D).
Furthermore, the role of the expression of inflammatory
cytokines was investigated in the HepG2 cells transfected
with PA+miR-124-3p inhibitor, PA+ inhibitor NC, PA, or
the control plasmids. According to the observations, IL1β, IL-6, and TNF-α cytokines were significantly elevated
in the PA+miR-124-3p inhibitor group than in the negative
controls (Figure 2E). Taken together, these observations
indicate that miR-124-3p facilitated cell autophagy but
repressed proliferation and inflammation via the PI3K/
AKT and JNK pathways.
3.3. MiR-124-3p targets PGM1
PGM1 has a role in congenital hyperinsulinemia. We thus
speculated that miR-124-3p negatively modulates PGM1,
inhibiting glucose uptake in HepG2 cells. To explore the
mechanism of miR-124-3p, miRanda (www.microrna.
org), PicTar (pictar.mdc-berlin.de/), and TargetScan
(www.targetscan.org) were used for the prediction of
miR-124-3p target genes. According to the findings,
miR-124-3p directly binds with PGM1 in the 3’UTR
region, as demonstrated in Figure 3A. Furthermore, the
luciferase activity was significantly increased in the MTPGM1+ miR-124-5p mimic compared to the WT-PGM1
miR-124-5p mimic but significantly reduced in the MT-

Figure 1. MiR-124-3p inhibits glucose uptake in HepG2 cells.
(A) Assessment of cell viability in IR HepG2 cell model through CCK-8, after treatment with various concentrations of palmitic acid
(PA); (B) The glucose uptake test done through glucose oxidase method. Various concentrations of PA were used in detecting the
glucose uptake capacity; (C) qRT-PCR to detect miR-124-3p mRNA expression following the induction of PA (0.8 mM); (D) qRT-PCR
to detect miR-124-3p mRNA expression in PA, PA+ inhibitor NC, or PA+miR-124-3p inhibitor transfected cells. (E) Determination of
Glucose consumption in PA, PA+ inhibitor NC or PA+miR-124-3p inhibitor transfected cells. * p < 0.05, ** p < 0.01.
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Figure 2. MiR-124-3p facilitates cell autophagy but repressed inflammation via depressing the PI3K/AKT and JNK pathways.
Western blot assays to detect; (A) PI3K/p-PI3K, AKT/p-AKT, GLUT4; (B) autophagy-related markers of LC3I/II, Beclin-1, p62, and
(C) JNK1/2, p-JNK1/2, and c-Jun; (D) EDU assay for the assessment of cell proliferation in PA, PA+ inhibitor NC or PA+miR-1243p inhibitor transfected cells; (E) qRT-PCR assessment of inflammatory cytokines IL-1β, IL-6, and TNF-α. A-E, in HepG2 cells of
each group. * p < 0.05; ** p < 0.01.

PGM1+miR-124-5p inhibitor compared to the WT-PGM1
+miR-124-5p inhibitor transfected cells (p < 0.01) (Figure
3B). The use of RT-qPCR and western blot to determine
the PGM1 mRNA and protein expression confirmed
significantly elevated PGM1 levels in PA+miR-124-3p
inhibitor compared to PA+ inhibitor NC (Figures 3C and
3D, P < 0.01). In summary, these observations showed that
PGM1 is a target of miR-124-3pin T2DM.
3.4. MiR-124-3p reduces glucose uptake via targeting
PGM1 to repress PI3K/AKT and JNK pathways
The mechanism of glucose consumption regulation by
miR-124-3p was also investigated. It was hypothesized that
miR-124-3p suppressed autophagy but enhanced glucose
uptake in HepG2 cells via repressing PGM1. To confirm
this theory, the HepG2 cells were separately cotransfected
with PA + miR-124-3p inhibitor + si-NC, PA + miR-124-
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3p inhibitor + si-PGM1, PA + inhibitor NC + si-NC, PA or
the control. The levels of PGM1 mRNA expressions were
then assessed through RT-qPCR and western blotting.
According to the results, the PGM1 expression was
significantly reduced in the PA and the PA + miR-124-3p
inhibitor + si-PGM1 compared to the controls and in the
PA + miR-124-3p inhibitor + si-NC group (Figures 4A and
4B). Further observations confirmed that PGM1 reversed
the suppression of miR-124-3p on the PI3K/AKT pathway
(Figure 4C). Meanwhile, PGM1 also downregulated
the autophagy effects of miR-124-3p (Figure 4D).
Contrastingly, p-JNK and c-Jun were significantly elevated
(Figure 4E, p < 0.01), indicating that PGM1 represses the
inhibition of miR-124-3p on the PI3K/AKT pathway.
Meanwhile, PGM1 restrained the suppression of miR-1243p on cell proliferation, inflammation, and glucose uptake
in HepG2 cells (Figures 4F–4H). No significant difference
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Figure 3. MiR-124-3p targets PGM1.
(A) miRanda (www.microrna.org), PicTar (pictar.mdc-berlin.de/), and TargetScan (www.targetscan.org) were used to predict
the design of the target site and mutation site of miR-124-3p and PGM; (B) Luciferase activity assay and determination of the
relative activity of each plasmid luciferase; (C, D) qRT-PCR and Western blot to detect PGM1 gene expression in each group
of HepG2 cells. ** p < 0.01.

was observed between the PA and the PA inhibitor NC
+ si-NC. In summary, miR-124-3p reduced glucose
consumption in HepG2 cells via targeting PGM1 to inhibit
PI3K/AKT and JNK pathways.
4. Discussion
T2DM is a risk factor for various microvascular and
macrovascular complications, leading to increased
mortalities in T2DM patients (Lovis et al., 2008). Fasting
blood glucose (FBG) and hemoglobin A1c (HbA1c) are
important indicators used to screen and diagnose diabetes.
However, only when the patient’s disease manifestations
have resulted in metabolic changes can FBG and HbA1c
indicators be used to screen and diagnose T2DM
(Rezk et al., 2016). Most T2DM patients have increased
plasma FFA levels proportional to the severity of insulin
resistance. Food intake with increased saturated or monosaturated fats is directly linked to high insulin resistance.
High circulating FFAs levels initiate and promote the
progression of insulin resistance. In this study, PA, a
representative FFA, enhanced the expression of miR-1243p in hepG2 cells. MiR-124-3p inhibited glucose uptake

in HepG2 cells, miR-124-3p facilitated cell autophagy, but
repressed inflammation via depressing the PI3K/AKT and
JNK pathways, miR-124-3p targeted and bound PGM1
and miR-124-3p reduced glucose uptake via targeting
PGM1 to repress PI3K/AKT and JNK pathways.
MiRNAs are small noncoding molecules found in
human tissues and various body fluids such as peripheral
blood (Tribolet et al., 2020). The miRNAs modulate gene
expression and repress protein translation by combining
with target genes’ 3’-untranslated region (UTR). As
mediators of various aspects of oxidative stress, the focus
on miRNAs has been increased (Bartel et al., 2004).
The role and mechanisms of miR-124-3p in various
diseases have been extensively studied. Overexpression
of miR-124-3p has been shown to suppress MEKK3
expression and downregulate the p38MAPK signaling
pathway expression, thus reducing the proliferation
of macrophages and promoting apoptosis in coronary
atherosclerotic mice model (Zhai et al., 2020). Li et al.
also reported that osteocyte-derived exosomes containing
miR-124-3p regulate Gal-3 expression in osteoblasts in
high-glucose conditions, indicating a possible mechanism
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Figure 4. MiR-124-3p reduces glucose uptake via targeting PGM1 to repress PI3K/AKT and JNK pathways.
(A) qRT-PCR for the determination of mRNA PGM1 expression in PA+miR-124-3p inhibitor + si-PGM1, PA+miR-124-3p inhibitor +
si-NC, PA+ inhibitor NC + si-NC, PA or control cells; (B) Western blot to detect PGM1 gene expression in PA+miR-124-3p inhibitor +
si-PGM1, PA+miR-124-3p inhibitor + si-NC, PA+ inhibitor NC + si-NC, PA or control cells; (C) Western blot to detect PI3K/p-PI3K,
AKT/p-AKT, GLUT4 gene expression in PA+miR-124-3p inhibitor + si-PGM1, PA+miR-124-3p inhibitor + si-NC, PA+ inhibitor NC
+ si-NC, PA or control cells; and (D) LC3I/II, Beclin-1, p62, (E ) JNK1/2, p-JNK1/2, and c-Jun genes expression ; (F) EDU to detect
the proliferation ability in in PA+miR-124-3p inhibitor + si-PGM1, PA+miR-124-3p inhibitor + si-NC, PA+ inhibitor NC + si-NC,
PA or control cells; (G) qRT-PCR assessment of proinflammatory cytokines IL-1β, IL-6 and TNF-α in in PA+miR-124-3p inhibitor +
si-PGM1, PA+miR-124-3p inhibitor + si-NC, PA+ inhibitor NC + si-NC, PA or control cells; (H) Glucose oxidase assay to detect the
glucose uptake capacity. * p < 0.05; ** p < 0.01.
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for diabetes mellitus-related pathologies of alveolar bone
(Li et al., 2020). MiR-124-3p has been reported as a tumor
suppressor against various tumors, including breast,
pancreatic, gastric, brain, and prostate cancers (Jia et al.,
2019).
In addition, miR-124-3p has a regulatory function in
metabolism. For instance, it regulates liver fatty acid and
cholesterol metabolism. In addition, miR-124-3p has been
reported to have a close relationship with the differentiation
of pancreatic cells and secretion of insulin through the
targeting of Noc2 and Rab27A (Lovis et al., 2019). MiR-1243p negatively modulates the differentiation of hepatocytes
into IPCs in vitro. Downregulation of miR-124-3p has also
been shown to influence the functioning of pancreatic-βcell via the targeting of secreted frizzled-related protein
5 (SFRP5) in Diabetes mellitus (Jiang et al., 2021). In the
current report, we demonstrate that microRNA-124-3p
suppresses glucose uptake via phosphoglucomutase 1/
phosphatidylinositol 3 kinase/protein kinase B and JNK
axis in insulin resistant cell model.
The PI3K/AKT pathway is necessary for normal
metabolism, and its imbalance results in obesity and
T2DM (Huang et al., 2018). The mammalian kinase target
of rapamycin (mTOR) is a negative regulator of autophagy.
The PI3K/ AKT/mTOR pathway activation enhances
phosphorylation of mTOR downstream effector genes,
further damaging autophagy activity (Liu et al., 2020).
Previous studies have shown that the PI3K-Akt-mTOR
pathway affects autophagy and mitigates IR (Song et al.,
2021). Our findings also reported enhanced cell autophagy
through miR-124-3p silencing via PI3K/AKT pathway
inhibition. Proliferation was also downregulated via the
suppression of PI3K/AKT and JNK pathways. In addition,
Inflammation has been considered the major reason for IR
(Shoelson et al., 2006), especially the activation of the JNK
signal is implicated in the loss of insulin function (Solinas

et al., 2017). Following the IR model construction, miR124-3p was increased in the PA-treated cells, indicating
that miR-124-3p might inhibit IR. Our findings, therefore,
confirmed that miR-124-3p has a role in suppressing the
proinflammatory cytokines IL-1β, TNF-α, and IL-6, thus
protecting against IR.
In this research, PGM1 was confirmed as the
immediate target of miR-124-3p. Through miR-124-3p
silencing, PGM1 was negatively regulated by miR-124-3p
in HepG2 cells. Further assays clarified that miR-124-3p
exerts biological functions by targeting PGM1. PGM1
is implicated in glycogen metabolism and the reversible
conversion of glucose 6-phosphate to glucose 1-phosphate
(Tegtmeyer et al., 2014). AMP-activated protein kinase
induces PGM1 by stimulating the phosphorylation of
histone deacetylase 8 (HDAC8) (Li et al., 2020). Hence, it
was hypothesized that HDAC8 is linked with miR-124-3p
during IR.
The limitation of this study is that it only confirms
in vitro data without any in vivo or clinical findings. The
findings may not be a true reflection of what occurs in the
clinical setting without further research. The use of one
type of cell line is also a limitation of this study.
In conclusion, this work confirms the role of miR-1243p in IR. Meanwhile, miR-124-3p facilitated autophagy
but reduced inflammation, proliferation, and glucose
uptake in HepG2 cells. Moreover, PGM1 was confirmed
to be a target gene of miR-124-3p. MiR-124-3p facilitates
autophagy but declines inflammation and glucose uptake
in HepG2 cells via targeting PGM1/PI3K/AKT. The use of
miR-124-3p to target PGM1 could be a novel and effective
alternative for handling insulin resistance hence treating
T2DM.
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